Articles tagged with Bacterial Pathogens
Researchers have discovered a new bacteriophage, CEV1, that can efficiently infect and kill E. coli O157:H7 in livestock gut systems. This natural approach could lead to an effective management strategy to eradicate the pathogen from livestock.
Researchers have deciphered the genome of Bacillus anthracis, a deadly soil bacterium that has been weaponized as a biowarfare agent. The analysis reveals that the bacterium's virulence is linked to specific genes and plasmids that enable it to thrive in environments rich in protein.
Researchers from The Institute of Genomic Research sequenced B. anthracis genome to improve vaccine design and drug development. Despite similarities with closely related bacteria, the study found unique genes giving B. anthracis its ability to thrive on protein-rich matter.
Researchers have discovered a complex system of communication in bacteria, known as quorum sensing, which allows them to sense the size of their colony and produce toxins. This system has significant potential for rapid pathogen sensing and novel antibiotic strategies.
A new study by The Institute for Genomic Research found close similarity among the DNA sequences of Chlamydiae pathogens, including C. trachomatis, C. pneumoniae, and C. muridarum, which cause human diseases such as blindness and pneumonia. Nearly 800 genes discovered in C. caviae were also found in these other bacteria.
Scientists identified a genetic key to TB bacteria survival in lung cells, revealing that SecA2 protein is crucial for virulence and secreting antioxidant molecules. This finding may aid treatment development and has implications for other disease-causing bacteria.
The study found that nearly a third of the E. faecalis genome consists of mobile or 'foreign' DNA, which plays a crucial role in helping the bacterium develop drug resistance. The analysis identified two sites in the genome related to vancomycin resistance, including a novel transposon carrying vanB resistance genes.
Experts are exploring ways to validate and interpret genetic information from microbes in court cases. The lack of established standards poses a challenge, but advancements in molecular technology have made it possible to analyze DNA and RNA levels with new insights.
Researchers are uncovering key genes and their interactions in diseases such as Down's Syndrome, autism, and tuberculosis. The goal is to identify markers for disorders like autism that could be detected by blood tests, and develop new treatments like drugs targeting gene adaptation mechanisms.
Researchers identified a complete iron-acquisition pathway in Staph. aureus, which also applies to Anthrax and Listeria. This discovery could lead to the development of new drugs to disrupt the pathway and prevent infection.
Scientists have discovered how the strep bacterium evades destruction by the human immune system, leading to new research on vaccine candidates and therapy interventions. The study found that GAS becomes more resilient to ingestion and killing by PMNs over time or produces factors that alter normal PMN function.
Researchers from UCSB and OSU have identified SAR 11 bacterioplankton, comprising up to 50% of the surface microbial community, using fluorescence in situ hybridization. This discovery opens up new avenues for understanding the role of microbes in natural systems and their impact on the ocean's ecosystem.
The research found that Helicobacter pylori can use hydrogen as an energy source, increasing its colonization in mice. The study showed that mice stomachs contained sufficient hydrogen to support the growth of H. pylori.
A new UGA study reveals that Helicobacter pylori and other human pathogens use molecular hydrogen as an energy source, leading to increased stomach colonization ability. The discovery has profound implications for the treatment of diseases such as gastric cancer and bacterial diarrhea illnesses.
Researchers identified key genes and metabolic pathways to differentiate the bacterium from related species, shedding light on its unique biology and slow growth rate.
Scientists at The Scripps Research Institute report that antibodies can kill bacteria through the production of hydrogen peroxide, which also leads to the formation of ozone. This discovery opens up possibilities for new antibody-mediated therapies for conditions ranging from bacterial and viral infections to cancer.
Researchers have developed a sepsis vaccine that provides outstanding protection by reducing inflammatory chemicals by nearly 95%. The vaccine targets endotoxins, which trigger the immune system's response to infection.
Researchers found that HIV-specific killer T cells in asymptomatic individuals can recognize and kill both laboratory strain and autologous virus-infected target cells. However, these cells in symptomatic patients with AIDS are no longer effective against their own mutated virus.
A new study reveals dispersin, a protein on the surface of E. coli bacteria, helps promote its ability to survive and spread in the gut. Dispersin is now being explored as a potential vaccine candidate due to its strong immune response-provoking properties.
Conducted studies show a strong majority of consumers favor irradiated ground beef, with surveys indicating 70-80% support the process when informed. Irradiation eliminates 99.9% of pathogens without changing taste or nutritional value.
Researchers at Purdue University have found that chlorine dioxide gas is highly effective in killing bacteria on food surfaces, particularly Listeria monocytogenes. The study showed significant reductions in bacterial populations on apple skin, stem cavity, and calyx using the gas.
UCSD researchers describe how Bacillus anthracis' lethal toxin disables macrophage signaling, allowing bacteria to spread unchecked. The study's findings open the door for developing an antidote to block the toxin's action.
Researchers have developed a new agent using phage enzymes that can specifically target and eliminate millions of anthrax bacteria within seconds. This targeted killer also shows promise as an anthrax detection and decontamination tool, with potential applications in mailrooms or subway stations.
A new study published in the New England Journal of Medicine found that specific bacterial strains are associated with flare-ups of chronic lung disease. The researchers discovered that it is not the volume of bacteria, but rather the particular strain within a species, that contributes to exacerbations.
DuPont scientists Richard Rees and W. Mark Barbour's team developed innovative technologies to minimize falling and flying glass during explosions, while also detecting harmful pathogens in food supplies with the BAX system. Their advancements strengthen global security and protection measures.
Researchers identified unique genes in a virulent GAS strain that were imported from bacteriophages, contributing to its high infectivity. The study provides new insights into the evolution of bacterial virulence and potential targets for novel treatments.
Researchers discover that Staph's toxic shock toxin inhibits production of other toxic proteins, leading to reduced disease severity. This breakthrough understanding sheds light on the complex ways Staph causes life-threatening infections.
A previously unrecognized function of myeloperoxidase has been identified, affecting vasculature through a pathway independent of chlorine bleach production. This discovery may lead to the development of new drugs to treat inflammatory vascular diseases and conditions like septic shock.
Researchers at Cornell University and Argonne National Laboratory have solved the structure of a key bacterial quorum-sensing protein, which could lead to new treatments for biofilm-related diseases. The discovery may also enable the design of targeted therapies to prevent harmful bacteria from forming biofilms.
Climate change is disrupting natural ecosystems, making life better for infectious diseases, says a team of experts. Warmer temperatures are causing disease outbreaks in coral reefs, oyster populations, and bird species, as well as increasing the spread of mosquito-borne illnesses like Rift Valley Fever.
Victor Nizet's award-winning research focuses on understanding the production of toxins by group A and B streptococcus in children, shedding light on potential treatments and disease prevention strategies. His work also explores anti-microbial peptides and the mechanism behind group B strep's ability to cause meningitis.
A UGA research team has identified a common bacterium as the cause of white pox disease, killing over 98% of elkhorn coral on some reefs near Key West. The disease is highly contagious and spreads rapidly between reefs, highlighting the impact of environmental changes on marine ecosystems.
A multi centre collaborative study found a two-thirds reduction in group C meningococci carriage after UK-wide vaccination. The programme protected both vaccinated and unvaccinated populations, providing valuable insights for future comprehensive vaccines.
Brenda A. Wilson's research explores Pasteurella multocida toxin's mechanism, revealing its impact on Gq protein and cell damage. The discovery could lead to new strategies for treating toxin-mediated diseases.
Researchers at the University of Illinois at Urbana-Champaign have identified the main bacteria associated with black band disease, a widespread coral disease characterized by a ring-shaped bacterial mat. The study found that cyanobacteria are a key factor in the development of the disease.
Researchers are working on developing new treatments for bioterrorism and drug resistance, including the use of bacteriophages to target specific bacteria. Understanding how microbes create biofilms is also crucial in preventing chronic infections.
Researchers have discovered three promising microorganisms that can infect and kill termites, providing a potential solution for termite infestations. The microorganisms appear to work by breaking down the termites' bodies through enzymatic degradation mechanisms.
Researchers have identified genes unique to group A Streptococcus bacteria that cause acute rheumatic fever, a leading cause of childhood heart disease. The study also reveals that genetic material from different strains can be swapped, enabling the spread of the disease.
Scientists identified a protein called RIN4 that bridges between bacterial pathogens and plant disease resistance proteins, allowing pathogens to evade the host's defenses. The discovery adds new knowledge to how bacterial pathogens target plant molecular machinery to make it more hospitable.
Researchers found bacterial proteins cause autoimmune disorders in APS patients by mimicking endogenous host proteins. High-affinity antibodies against these proteins were pathogenic and induced symptoms similar to APS. The study raises concerns about vaccine risks, particularly the tetanus toxoid protein.
A study of German subjects found periodontal disease bacteria in carotid artery samples, supporting the 'infectious burden' hypothesis that oral infection plays a role in atherogenesis. The study also identified multiple types of bacteria, suggesting a complex relationship between gum disease and cardiovascular disease.
Bacteria use transporters to pump iron into cells, a process that could be exploited for new antibiotic designs. Researchers deciphered the structure of an iron transporter and found it undergoes dramatic changes when transporting iron.
A recent study reveals that Staphylococcus aureus, a leading cause of hospital-borne infections, is part of a few massive superbug families. These bacteria have spread globally and can be tracked through unique genetic fingerprints, suggesting new targets for disease-fighting drugs.
A University of Toronto geneticist has discovered a process to clarify the relationship between bacterial pathogens and their plant hosts. By developing a functional screen, Professor David Guttman identified more type III effectors in plant pathogen Pseudomonas syringae than in any other animal or plant pathogen.
Plant cells employ a sophisticated immune system with a thick cell wall and Leucine-rich repeat receptor kinase that detects bacterial flagellin, triggering gene expression and immune response. The discovery sheds light on plant resistance to pathogens and paves the way for engineering pathogen-resistant crops.
Researchers used DNA arrays to understand macrophage responses, revealing that specific bacterial components can activate the immune system. This knowledge will help design therapeutics with fewer side effects and improve disease treatment.
A potent bacterial toxin called streptolysin S (SLS) plays a crucial role in producing necrotizing fasciitis, a severe infection also known as 'flesh-eating disease'. Researchers discovered that SLS is essential for both group A Streptococcus and group G Streptococcus bacteria to cause the infection.
Researchers have found that bacteria use an analogous integrated communications system to sense chemical signals. The discovery may lead to new vaccine strategies and the creation of surfaces that naturally repel pathogenic microbes.
Researchers at Rockefeller University have developed a novel approach to combating antibiotic-resistant infections by using a natural enzyme derived from tiny viruses that live inside bacteria. This enzyme can target and kill disease bacteria on the surface of cells, providing an alternative method for combating resistant pathogens.
Cornell students developed a web-based software and database to track bacterial strain characteristics and visualize molecular subtypes, allowing researchers to quickly analyze outbreaks and epidemics. The new tool reduces manual comparisons from days to minutes, aiding scientists in tracking virulent bacteria.
Researchers at UCSD and VA San Diego Healthcare System discovered a natural antibiotic peptide called cathelicidin, which inhibits microbe growth and plays a crucial role in mammalian innate immunity. The study provides hope for developing new treatments and a blood test to identify individuals susceptible to bacterial infections.
Scientists have identified a novel family of peptide antibiotics, Piscidins, isolated from the tissues of hybrid striped bass and found in mast cells. These potent compounds show broad-spectrum activity against various bacterial pathogens, including multi-drug-resistant strains.
Researchers studied coral outbreaks off the island of Curacao, finding high concentrations of metals and human pathogens near major oil refineries. The team suggests that environmental stresses caused by pollution may be weakening corals' resistance to bacterial infection.
Researchers at the University of Rochester have developed a smart bandage that can detect bacteria and provide instant diagnosis, changing color to indicate the presence of Gram-positive or negative bacteria. The bandage is part of a larger 'smart medical home' system that aims to give people more control over their health.
This study provides evidence for pathogen-specific gene responses in dendritic cells, offering insights into the tailored immune defense mechanism. The research uses DNA array technology to investigate how dendritic cells discriminate between pathogens and activates specific genes to initiate an immune response.
Researchers at AgraQuest have developed a natural pesticide called Serenade that targets various fungal and bacterial diseases. It is highly effective and nontoxic to humans, birds, fish, and beneficial insects, making it suitable for integrated pest management systems.
Researchers at Ohio State University have developed a new DNA-based vaccine approach that successfully immunizes mice against anthrax. The vaccine uses combinations of two gene products produced by the bacteria responsible for causing anthrax, resulting in strong immune responses.
A bacterial peptide has been identified as a key regulator of host responses to infection. This discovery opens up new avenues for the development of therapies targeting this process.
Students at IIT's Interprofessional Program developed a blood sniffing e-nose that can identify hundreds of specific scent signatures, potentially cutting testing time down to minutes. The technology uses electronic noses sensitive to microscopic particles, similar to the receptors in the human nose.
Researchers have discovered that chemokine expression plays a crucial role in enhancing antibacterial immunity. This finding is significant for the development of novel therapeutic strategies against bacterial infections.